Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Morten research group aims to bring forward the day when ME/CFS can be cured, through cutting-edge biomedical research.


ME/CFS is a devastating disease that affects over 250,0001 individuals in the UK. Despite being at least as disabling as diseases such as Multiple Sclerosis (MS) and Congestive Heart Failure2ME/CFS remains one of the most poorly funded diseases. 

The disease is often referred to as both and or Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS). ME/CFS is a multi-organ, life-changing disease that manifests with a range of symptoms - some of which vary from patient to patient. As such the complexity of symptoms can make the condition difficult to diagnose. Learn more about the signs and symptoms here. 

At present, there is no reliable biomarker for ME/CFS. Diagnoses of ME/CFS are based on manifesting clinical symptoms and there is high inter-patient variability of more complex symptoms/auxiliary and physiological abnormalities, however, amongst physicians, crucially, the symptom of post-exertional malaise (PEM) is increasingly being recognised as inseparable to the manifestation of the disease. Read more about diagnosis here.



Biomarker Research

Finding a Biomarker 

We are currently exploring the potential utility of Raman spectroscopy to diagnose ME/CFS. 

Read more.

Disease Process

Understanding Disease Process 

We are utilising multiple technologies to try to understand which factors could be driving the disease. 

Read more.

L Form

L-Form Bacteria in ME/CFS

Determining if abnormal profiles of L-form bacteria could be causal in ME/CFS.

Read more.



[1] Nacul LC, Lacerda EM, Pheby D, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med 2011; 9: 91.  

[2] Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996; 101: 281–90.



Our team

Related research themes